Original Articles

Clinicopathological Spectrum of Indian Adolescent and Young Adults (AYA) Gynecological Tumors: A Retrospective Analysis

Abstract

Background: Cancers in adolescents and young adults (AYA) represents a bridge between childhood and elderly incidence curves of cancers demanding tailored approaches and management of their distinct presentations. The literature on Indian gynecological cancer patients aged 15 to 39 years is limited. Thus, our study aims to determine the distribution of gynecological tumors, modalities of diagnosis, and treatment employed in managing these patients. Methods: A retrospective cross-sectional analysis of patients from 15 to 39 years of age who presented with gynecological tumors was done. The data of all the patients during the study period was recorded and statistically analyzed. Results: The study included 50 patients. The tumors observed were ovarian (78%), cervical (16%) and uterine (6%) in origin. Histopathological diagnosis was benign (46%), malignant (50%) and borderline tumor (4%). CA125 was the most frequently done tumor marker and was raised in 17 cases (34%), of which 13 were malignant. The tumor size was greater than 10 cm in 56% of cases. Definitive management strategies included cystectomy/ salpingo-oopherectomy (44%), total hysterectomy and salpingo-oopherectomy (38%), chemoradiation (14%), and conization (2%). The most common benign and malignant ovarian tumors were serous cystadenoma and serous cystadenocarcinoma, respectively. All uterine malignancies were sarcomas. Conclusion: Ovarian tumors are the most common gynecological malignancies in adolescents and young adults. Timely diagnosis and comprehensive and multidisciplinary management can improve survival and preserve future fertility in these young patients.
1. Adolescent and Young Adult Oncology Progress Review Group. Closing the gap: research and care imperatives for adolescents and young adults with cancer (NIH Publication No. 06-6067). Bethesda, MD: Department of Health and Human Services, National Institutes of Health, and the LIVESTRONG Young Adult Alliance; 2006. Available from: https://www.cancer.gov/types/aya/research/ayao-august-2006.pdf.
2. Sathishkumar K, Chaturvedi M, Das P, Stephen S, Mathur P. Cancer incidence estimates for 2022 & projection for 2025: result from National Cancer Registry Programme, India. Indian journal of medical research. 2022 Oct 1;156(4&5):598-607
3. Singh R, Shirali R, Chatterjee S, Adhana A, Arora RS. Epidemiology of cancers among adolescents and young adults from a tertiary cancer center in Delhi. Indian Journal of Medical and Paediatric Oncology. 2016 Apr;37(02):90-4.
4. Bleyer A, Viny A, Barr R. Cancer in 15-to 29-year-olds by primary site. The oncologist. 2006 Jun 1;11(6):590-601.
5. Wu X, Groves FD, McLaughlin CC, Jemal A, Martin J, Chen VW. Cancer incidence patterns among adolescents and young adults in the United States. Cancer Causes & Control. 2005 Apr;16:309-20.
6. Triarico S, Capozza MA, Mastrangelo S, Attinà G, Maurizi P, Ruggiero A. Gynecological cancer among adolescents and young adults (AYA). Annals of translational medicine. 2020 Mar;8(6):397.
7. Sharma D, Singh G. Spectrum of cancer in adolescents and young adult: An epidemiological and clinicopathological evaluation. Indian Journal of Cancer. 2016 Jul 1;53(3):457-9.
8. Wohlmuth C, Wohlmuth-Wieser I. Gynecologic malignancies in children and adolescents: how common is the uncommon?. Journal of Clinical Medicine. 2021 Feb 12;10(4):722.
9. Farghaly SA. Gynecologic cancer in the young female: clinical presentation and management. Adolescent and pediatric gynecology. 1992 Jun 1;5(3):163-70.
10. Scholler N, Urban N. CA125 in ovarian cancer. Biomarkers in medicine. 2007 Dec 1;1(4):513-23.
11. Jung SE, Lee JM, Rha SE, Byun JY, Jung JI, Hahn ST. CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. Radiographics. 2002 Nov;22(6):1305-25.
12. Gupta B, Guleria K, Suneja A, Vaid NB, Rajaram S, Wadhwa N. Adolescent ovarian masses: A retrospective analysis. Journal of Obstetrics and Gynaecology. 2016 May 18;36(4):515-7.
13. Johnson NL, Head KJ, Scott SF, Zimet GD. Persistent disparities in cervical cancer screening uptake: knowledge and sociodemographic determinants of Papanicolaou and human papillomavirus testing among women in the United States. Public Health Reports. 2020 Jul;135(4):483-91.
14. Bentivegna E, Gouy S, Maulard A, Chargari C, Leary A, Morice P. Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. The Lancet Oncology. 2016 Jun 1;17(6):e240-53.
15. Pan S, Jiang W, Xie S, Zhu H, Zhu X. Clinicopathological features and survival of adolescent and young adults with cervical cancer. Cancer Control. 2021 Oct 1; 28:10732748211051558.
16. Li AJ, Giuntoli RL, Drake R, Byun SY, Rojas F, Barbuto D, Klipfel N, Edmonds P, Miller DS, Karlan BY. Ovarian preservation in stage I low-grade endometrial stromal sarcomas. Obstetrics & Gynecology. 2005 Dec 1;106(6):1304-8.
17. Sohail R, Kanwal S, Murtaza A, Haq B. Endometrial stromal sarcoma in a 20-year-old woman. BMJ Case Reports CP. 2019 Dec 1;12(12):e228874.
Files
IssueVol 16 No 3 (2024) QRcode
SectionOriginal Articles
Keywords
adolescent and young retrospective analysis epithelial tumors sarcoma

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Singh P, Chauhan M, Dahiya P, Malhotra V, Chaudhary S, Verma M, Kalra P. Clinicopathological Spectrum of Indian Adolescent and Young Adults (AYA) Gynecological Tumors: A Retrospective Analysis. Basic Clin Cancer Res. 2025;16(3):151-159.